Arteriovenous Fistula Tissue Bank

The recruitment status of this study is unknown because the information has not been verified recently.

Verified July 2010 by University of Nebraska.
Recruitment status was Recruiting

Sponsor:

Information provided by:

University of Nebraska

ClinicalTrials.gov Identifier:

NCT00836862

First received: February 3, 2009

Last updated: July 15, 2010

Last verified: July 2010

History of Changes

Tracking Information
First Received Date ^ICMJE	February 3, 2009
Last Updated Date	July 15, 2010
Start Date ^ICMJE	February 2009
Estimated Primary Completion Date	November 2011 (final data collection date for primary outcome measure)
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	Complete list of historical versions of study NCT00836862 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Arteriovenous Fistula Tissue Bank
Official Title ^ICMJE	Arteriovenous Fistula Tissue Bank
Brief Summary	This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Retention: Samples With DNA Description: Serum, Whole Blood, Tissue
Sampling Method	Probability Sample
Study Population	Patients will be eligible if they are 19 years of age or greater and have placement of an arteriovenous fistula planned witin 30 days.
Condition ^ICMJE	Kidney Failure, Chronic
Intervention ^ICMJE	Other: Biologic specimens Banking of serum, DNA and tissue
Study Group/Cohort (s)	Arteriovenous Fistula Intervention: Other: Biologic specimens
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Recruiting
Estimated Enrollment ^ICMJE	50
Completion Date	Not Provided
Estimated Primary Completion Date	November 2011 (final data collection date for primary outcome measure)
Eligibility Criteria ^ICMJE	Inclusion Criteria: Age 19 years of age or greater Arteriovenous fistula placement for hemodialysis access scheduled within 30 days Exclusion Criteria: Incompetent to provide informed consent
Gender	Both
Ages	19 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Not Provided
Location Countries ^ICMJE	United States

Administrative Information
NCT Number ^ICMJE	NCT00836862
Other Study ID Numbers ^ICMJE	482-08-EP
Has Data Monitoring Committee	No
Responsible Party	Troy J. Plumb, MD, University of Nebraska Medical Center
Study Sponsor ^ICMJE	University of Nebraska
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	University of Nebraska
Verification Date	July 2010
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top